Integrating Behavioral Therapy in the Management of Temporomandibular Disorders: A Comprehensive Evaluation Using DC/TMD Axis II Criteria
CompletedNot applicableNCT06774196
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates the efficacy of behavioral therapy, including Cognitive Behavioral Therapy (CBT), relaxation techniques, and biofeedback, in managing Temporomandibular Disorders (TMD). It aims to address both the physical and psychological aspects of TMD, focusing on pain reduction, improved jaw function, and alleviating psychological distress such as anxiety and depression. Participants are randomized into two groups: an intervention group receiving behavioral therapy and a control group receiving standard care. Outcomes will be assessed using validated tools to measure pain intensity, jaw function, and psychological well-being at baseline, post-treatment, and at a 6-month follow-up. This research seeks to establish the role of behavioral therapy as a key component in the comprehensive management of TMD.
Study details
- Official title
- Integrating Behavioral Therapy in the Management of Temporomandibular Disorders: A Comprehensive Evaluation Using DC/TMD Axis II Criteria
- Interventions
- Behavioral: Behavioral Therapy Group
- Procedure: Standard Care Group
- Sponsor
- King Khalid University
- Start date
- 2025-03-05
- Primary completion
- 2025-03-05
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Saudi Arabia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged 18-65 years. * Diagnosed with Temporomandibular Disorders (TMD) based on DC/TMD Axis I and Axis II criteria. * Presenting with symptoms such as jaw pain, limited jaw movement, or psychosocial distress (anxiety, depression). * Willing and able to provide informed consent. * Able to comply with the study protocol and attend all follow-up visits. Exclusion Criteria: * Severe systemic diseases or other neurological conditions that could interfere with treatment or outcomes. * History of psychiatric disorders unrelated to TMD, such as schizophrenia or bipolar d disorder. * Pregnant or lactating women. * Use of medications or treatments within the past month that could influence study outcomes (e.g., corticosteroids, strong analgesics). * Individuals with severe dental or maxillofacial conditions requiring immediate surgical intervention. * Non-compliance with previous medical advice or treatment for TMD. Participants unable to understand or follow the study procedures due to language barriers or cognitive impairments.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06774196